Mental Status and Dementia Tests: Clinical Trials

185 trials of Mental Status and Dementia Tests, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 completed, 32 unknown, 27 recruiting, 16 terminated. 69 Not applicable, 19 Phase 2, 8 Phase 3, 7 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable69Completed 28, Unknown 16, Recruiting 13, Active not recruiting 3, Not yet recruiting 3, Terminated 3, Withdrawn 2, Suspended 1
Phase 219Completed 10, Active not recruiting 4, Terminated 4, Recruiting 1
Phase 38Active not recruiting 3, Completed 3, Not yet recruiting 2
Phase 17Active not recruiting 3, Completed 2, Terminated 2
Phase 41Unknown 1

Follow Mental Status and Dementia Tests: new trials by email Literature Review of Mental Status and Dementia Tests trials Research Report on Mental Status and Dementia Tests

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Radiation After Surgery to Observation After Surgery in Patients With Clinical Low-Risk, Molecular High-Risk Meningioma, and Evaluating Observation After Surgery in Patients With Clinical and Molecular Low-Risk Meningioma
Patient Observation, Magnetic Resonance Imaging, Biospecimen Collection - Grade 1 Meningioma, Grade 2 Meningioma
Phase 3Not yet recruitingNRG Oncology4642027-01-282026-08-25
Cognitive Assessment And Post-Operative Complications After Surgery: Linking Anaesthesia And Risk
Montreal Cognitive Assessment, biomarkers - Cognitive Impairment, Cognitive Impairment, Mild
Not yet recruitingUniversity of Edinburgh402026-11-012026-09-24
Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Treatment administration (Levetiracetam or placebo), Neuroimaging, National Institute of Health Stroke Scale (NIHSS) - Spontaneous Intracerebral Hemorrhage
Phase 3Not yet recruitingHospices Civils de Lyon5802026-10-022026-08-12
A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial
Accelerometry, Aerobic Exercise, Electronic Health Record Review - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableNot yet recruitingMayo Clinic102026-10-012026-06-16
Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electronic Patient-reported Outcome Application in Patients With IDH-mutated Glioma
Neurocognitive assessment, Questionnaries QoL, Resilience Pro Application - Oncology, Glioma
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris802026-09-012026-02-27
The Neurocognitive Bases of Trust in Intellectual Disability
Confidence adjustment assessment, clinical assessment, Cognitive assessment - Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS)
RecruitingHospices Civils de Lyon1122026-07-172026-08-05
Characterization of the Natural History of Microduplication Syndrome 7q11.23
clinical assessment, Parental questionnaires, Cognitive assessment - 7q11.23 Microduplication Syndrome (7DUP), Autism Spectrum Disorder (ASD)
Not applicableRecruitingHospices Civils de Lyon152026-07-152026-08-03
Optical Imaging in X-linked Disorders.
Clinical assessment, Parental questionnaires, Cognitive assessment - Fragile X Syndrome (FXS), Creatine Transporter Deficiency
Not applicableRecruitingHospices Civils de Lyon1182026-03-302026-05-15
Post Stroke Cognitive Impairment
Cognitive assessment: Montreal Cognitive Assessment (MoCA), Cognitive Assessment for Stroke patients, Oxford cognitive screening, Trail Making Test B, Digit Span-Backward, verbal fluency, Clinical Dem - Cognition - Other
Not yet recruitingAssiut University4002026-01-012026-01-06
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
Activity Tracking, Biospecimen Collection, Cognitive Assessment - Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia
Not applicableRecruitingUniversity of Washington502025-10-152026-08-19
Minimal-flow Anesthesia and Cognitive Outcomes in Elderly Surgical Patients
Mini-Mental State Examination - Postoperative Cognitive Dysfunction
Not applicableCompletedAnkara Etlik City Hospital902025-10-032026-03-18
Communication Training in Hearing Aid Users
Cognitive screening, Audiological Assessment, Questionnaires - Hearing Loss, Age-Related, Hearing Aids
Not applicableCompletedUniversity Ghent572025-09-162026-09-01
Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials
Blood test, Interrogation of the subject, Cognitive assessment - Frontotemporal Lobar Degeneration (FTLD)
Not applicableRecruitingCentre Hospitalier Universitaire Dijon202025-08-182025-08-24
Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias
MMSE and blood draw - Alzheimer Disease
Not applicableRecruitingCentre Hospitalier Universitaire de Nice2502025-07-012026-06-18
Sarcopenia in Gestational Diabetes
Sarcopenia tests (for muscle mass, muscle function, physical performance), Oral Glucose Tolerance Test, Montreal Cognitive Assessment - Sarcopenia, Gestational Diabetes Mellitus (GDM)
RecruitingIstituto di Neuroscienze Consiglio Nazionale delle Ricerche2002025-05-282025-11-21
Study of Emotional Dysregulation in Complex Post-Traumatic Stress Disorder
Self-questionnaires, Cognitive assessment, Momentary Ecological Assessment (EMA) - Complex Post-Traumatic Stress Disorder (CPTSD), Borderline Personality Disorder (BPD)
Not applicableNot yet recruitingUniversity Hospital, Strasbourg, France1702025-03-012025-02-26
Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
Assessment of severity of ICD (impulse control disorders), Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors, Assessment of quality of life - Parkinson Disease
Not yet recruitingUniversity Hospital, Strasbourg, France1002025-02-012025-01-01
Characterizing the Impact of Presbyphonia on Social Interaction
PhoRTE Program, University of California Los Angeles (UCLA) Loneliness Scale, Social Disconnectedness Scale - Presbyphonia
Not applicableRecruitingMatthew R. Hoffman252025-01-102025-07-17
Child Cognitive-Affective Resilience Following 13-11 Event : A Pluridisciplinary Study of Intergenerational Transmission of a Traumatic Event
MRI, Psychological assessment, Cognitive assessment - Intergenerational Trauma
Not applicableRecruitingInstitut National de la Santé Et de la Recherche Médicale, France9602024-12-172026-10-19
Natural History Study of Children With LAMA2-related Dystrophies
Motor evaluations, Cognitive assessment, Pulmonary function test - Merosin Deficient Congenital Muscular Dystrophy
RecruitingInstitut de Myologie, France402024-12-052024-12-12

Showing 20 of 185. Sign in to see all of them.

Conditions studied

Brain Neoplasms (21)  ·  Cognitive Dysfunction (20)  ·  Breast Neoplasms (17)  ·  Fatigue (8)  ·  Parkinson Disease (8)  ·  Alzheimer Disease (7)  ·  Dementia (7)  ·  Emergence Delirium (7)  ·  Neoplasms (7)  ·  Carcinoma, Non-Small-Cell Lung (6)  ·  Central Nervous System Neoplasms (6)  ·  Colonic Neoplasms (6)  ·  Colorectal Neoplasms (6)  ·  Delirium (5)  ·  Glioma (5)

Sponsors

Case Comprehensive Cancer Center (8)  ·  M.D. Anderson Cancer Center (7)  ·  Children's Oncology Group (6)  ·  Hospices Civils de Lyon (5)  ·  National University Hospital, Singapore (4)  ·  Ohio State University Comprehensive Cancer Center (4)  ·  Wake Forest University Health Sciences (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Brigham and Women's Hospital (3)  ·  Centre Hospitalier Universitaire Dijon (3)  ·  Centre Hospitalier Universitaire de Saint Etienne (3)  ·  City of Hope Medical Center (3)  ·  Institut National de la Santé Et de la Recherche Médicale, France (3)  ·  University Hospital, Strasbourg, France (3)  ·  University of Florida (3)

Countries

United States (84)  ·  France (38)  ·  Canada (9)  ·  Turkey (Türkiye) (9)  ·  United Kingdom (9)  ·  Belgium (6)  ·  Australia (5)  ·  Singapore (4)  ·  Italy (3)  ·  New Zealand (3)  ·  Puerto Rico (3)  ·  South Korea (3)  ·  Taiwan (3)  ·  China (2)  ·  Spain (2)

Top investigators

Cynthia Owusu, MD, MSC (3)  ·  Lian Kah Ti (3)  ·  Euitae Kim, Ph. D. (2)  ·  Jing Li (2)  ·  Munevver Kayhan, Medical Doctor (2)  ·  Ali Choucair (1)  ·  Allan Y. Chen, MD, PhD (1)  ·  Anat V Lubetzky, PhD (1)  ·  Andreas Hoeft, M.D. (1)  ·  Angela Bader, MD, MPH (1)  ·  Anna Derajinski, MD (1)  ·  Anna Halpern, MD (1)  ·  Antoine Verger, MD, PhD (1)

Results publications

PMID 15817019, PMID 16549835, PMID 18625866, PMID 20588118, PMID 21233711, PMID 21921797, PMID 22851612, PMID 23275424, PMID 23573223, PMID 23606736, PMID 24120271, PMID 24291380, PMID 24323708, PMID 24366929, PMID 24471651, PMID 24506437, PMID 24999040, PMID 25366641, PMID 25492923, PMID 25654299, PMID 25668423, PMID 25700290, PMID 25740785, PMID 26285662, PMID 26598177, PMID 27071646, PMID 27165892, PMID 27355762, PMID 27692728, PMID 27744512, PMID 29141164, PMID 29159840, PMID 29684893, PMID 30910550, PMID 31221697, PMID 31386061, PMID 31518280, PMID 31755936, PMID 33175114, PMID 33213758, PMID 33236783, PMID 33751221, PMID 34988299, PMID 35802849, PMID 36060611, PMID 36306532, PMID 37060708, PMID 37369917, PMID 37580874, PMID 37674711

NIH funding

P30CA043703 (4), UG1CA189955 (4), P30CA033572 (3), U10CA098543 (3), P30CA014089 (2), U10CA180886 (2), 2016 (1), 2019 (1), N01CM00039 (1), P30CA012197 (1), P30CA016672 (1), P30CA023074 (1), P30CA060553 (1), P30CA068485 (1), P50CA095060 (1)